Filtrer efter Last updated date SelectEfterFørFrom - To Dato Slutdato Denne uge Denne måned Seneste uge Seneste måned Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Efterlad dette felt tomt Filter Resultater (3800) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Efterlad dette felt tomt Public consultation opens on European Medicines Agency's draft guide on monitoring of medical literature 5 juni 2014NewsCorporateMedicines Ranbaxy, Toansa assessment concluded: no risk to public health 5 juni 2014Press releaseCorporate European Medicines Agency closed 9 June 2014 5 juni 2014NewsCorporateMedicines Update on investigation by Italian authorities into the supply of stolen medicines 3 juni 2014NewsCorporate Regulatory information – revised guideline on acceptability of names for human medicines is published 3 juni 2014NewsCorporateRegulatory and procedural guidance European Medicines Agency welcomes publication of the Clinical Trials Regulation 28 maj 2014Press releaseCorporateMedicines European Medicines Agency closed 29-30 May 2014 27 maj 2014NewsCorporateMedicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 May 2014 23 maj 2014NewsHuman European Medicines Agency recommends approval of Gazyvaro for chronic lymphocytic leukaemia 23 maj 2014Press releaseHumanMedicines European Medicines Agency recommends first-in-class medicine for treatment of Duchenne muscular dystrophy 23 maj 2014Press releaseHumanMedicines 1 … 194 195 196 197 198 Page 198 of 380 199 200 201 202 … 380
Public consultation opens on European Medicines Agency's draft guide on monitoring of medical literature 5 juni 2014NewsCorporateMedicines
Update on investigation by Italian authorities into the supply of stolen medicines 3 juni 2014NewsCorporate
Regulatory information – revised guideline on acceptability of names for human medicines is published 3 juni 2014NewsCorporateRegulatory and procedural guidance
European Medicines Agency welcomes publication of the Clinical Trials Regulation 28 maj 2014Press releaseCorporateMedicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 May 2014 23 maj 2014NewsHuman
European Medicines Agency recommends approval of Gazyvaro for chronic lymphocytic leukaemia 23 maj 2014Press releaseHumanMedicines
European Medicines Agency recommends first-in-class medicine for treatment of Duchenne muscular dystrophy 23 maj 2014Press releaseHumanMedicines